US equities |
SPCX $174.63 ▲+2.07% NVDA $241.78 ▲+1.21% MU $1,073.55 ▲+0.90% MRVL $298.45 ▲+10.03% AMD $645.45 ▲+2.17% SNDK $1,694.45 ▼-0.57% TSLA $380.76 ▲+0.54% META $740.07 ▼-0.25%
FinancialContent

Latest News about LEXXW

Recent news which mentions LEXXW

Lexaria's Formulated Cannabidiol Showed Reduction In Pro-Inflammatory Biomarkers Associated with Heart Diseases
Tickers LEXX LEXXW
Tags News Benzinga Briefs
From Benzinga
Lexaria's DehydraTECH-CBD Diabetes Study Demonstrates Weight Loss, Improved Triglyceride And Cholesterol Levels
Tickers LEXX LEXXW
Tags Penny Stocks Market News Markets
From Benzinga
Lexaria's DehydraTECH CBD Hypertension Study Dosing Complete With No Serious Adverse Events
Tickers LEXX LEXXW
Tags Market News Penny Stocks Markets
From Benzinga
Lexaria Bioscience (NASDAQ: LEXX) Secures Patent For DehydraTECH To Deliver Antivirals
Tickers LEXX LEXXW
Tags General Benzinga LEXXW
From Benzinga
Lexaria Bioscience (NASDAQ: LEXX) Commences Its Most Comprehensive Study To Date
Tickers LEXX LEXXW
Tags General Partner Content InvestorBrandNetwork
From Benzinga
Lexaria Bioscience (NASDAQ: LEXX) Issues Update On Human Nicotine Study
Tickers LEXX LEXXW
Tags Market News Penny Stocks Biotech
From Benzinga
Lexaria Bioscience Commences DehydraTECH-CBD Epilepsy Research Program
Tickers LEXX LEXXW
Tags Penny Stocks Market News Biotech
From Benzinga